Browse by Publication
|Up a level|
Number of items: 10.
Gall, A; Kaye, S; Hue, S; Bonsall, D; Rance, R; Baillie, GJ; Fidler, SJ; Weber, JN; McClure, MO; Kellam, P; +179 more... (2013) Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters. Retrovirology, 10. p. 8. ISSN 1742-4690 DOI: 10.1186/1742-4690-10-8 Full text not available from this repository.
Kraft, CS; Basu, D; Hawkins, PA; Hraber, PT; Chomba, E; Mulenga, J; Kilembe, W; Khu, NH; Derdeyn, CA; Allen, SA; +2 more... (2012) Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses. Retrovirology, 9. p. 22. ISSN 1742-4690 DOI: 10.1186/1742-4690-9-22
Wight, DJ; Boucherit, VC; Nader, M; Allen, DJ; Taylor, IA; Bishop, KN; (2012) The gammaretroviral p12 protein has multiple domains that function during the early stages of replication. Retrovirology, 9. p. 83. ISSN 1742-4690 DOI: 10.1186/1742-4690-9-83
Hué, S; Gray, ER; Gall, A; Katzourakis, A; Tan, CP; Houldcroft, CJ; McLaren, S; Pillay, D; Futreal, A; Garson, JA; +3 more... (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology, 7 (1). p. 111. ISSN 1742-4690 DOI: 10.1186/1742-4690-7-111 Full text not available from this repository.
de Silva, TI; Turner, R; Hue, S; Trikha, R; van Tienen, C; Onyango, C; Jaye, A; Foley, B; Whittle, H; Rowland-Jones, SL; +1 more... (2010) HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form. Retrovirology, 7. p. 82. ISSN 1742-4690 DOI: 10.1186/1742-4690-7-82 Full text not available from this repository.
van der Loeff, MFS; Larke, N; Kaye, S; Berry, N; Ariyoshi, K; Alabi, A; van Tienen, C; Leligdowicz, A; Sarge-Njie, R; da Silva, Z; +7 more... (2010) Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology, 7. ISSN 1742-4690 DOI: 10.1186/1742-4690-7-46
Berthe, A; Meda, N; Traore, IT; Some, J; Salouka, S; Sanou, L; Some, F; Rouamba, J; Ouedraogo, D; M'Boutiki, G; +3 more... (2009) Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso. [Conference or Workshop Item]
Latka, M; Grey, G; Fielding, K; Bekker, L; Mlisana, K; Nchabeleng, M; Debruin, G; Allen, M; Kublin, J; Churchyard, G; (2009) Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine. [Conference or Workshop Item]
Njai, HF; Gali, Y; Vanham, G; Clybergh, C; Jennes, W; Vidal, N; Butel, C; Mpoudi-Ngolle, E; Peeters, M; Ari?n, KK; (2006) The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology, 3. p. 40. ISSN 1742-4690 DOI: 10.1186/1742-4690-3-40
Moore-Rigdon, KL; Kosloff, BR; Kirkman, RL; Morrow, CD; (2005) Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells. Retrovirology, 2. p. 21. ISSN 1742-4690 DOI: 10.1186/1742-4690-2-21